Equillium

Developer of therapies for treating autoimmune and inflammatory disorders

placeSan Diego, California, United States calendar_todayFounded 2017 groups36 employees language equilliumbio.com

Registered entities

Social engagement

Social engagement: 5.7K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include ADAR1 Capital Management, Janus Henderson Investors.

Investor typeCountShare
Venture capital338%
Private equity225%
Other / undisclosed338%

Recent activity

18 Jun 2026
Event
American Association of Immunologists meeting
8 Jun 2026
Leadership hire
Chief Development Officer
22 May 2026
Event
Virtual investor event on Aryl Hydrocarbon Receptor (AhR) and miR-124 Axis
Coming soon